Article Listing - Australia's CSL enters $3.1 billion agreed bid for USA's Telcris Biotherapeutics

EC PHARMA MARKET FORECASTS TO 1996

27 April 1992

The European Community pharmaceutical market is expected to continue growing over the next five years at a rate in excess...

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

Highlighting its ongoing R&D in its recently released annual report for 1991, Denmark's Novo Nordisk notes that it intends to...

MEIJI MILK PRODS TEST-MARKETING PREGNANCY TEST

27 April 1992

Meiji Milk Products of Japan has begun test-marketing a pregnancy test which is produced by Ortho Pharmaceutical Corp of the...

NEUTOGENA ACQUIRES INTEREST IN CELLEGY

27 April 1992

Neutrogena Corp has acquired a minority interest in Cellegy Pharmaceuticals, a dermatological products R&D company. Full terms of the agreement...

FRENCH GOV'T SUPPORT FOR R-P

27 April 1992

Rhone-Poulenc is to receive French government financing worth 610 million francs ($108 million) for its biotechnology R&D program. The program...

CONTROVERSIAL ALLERGY THERAPIES

27 April 1992

A report from the UK Royal College of Physicians concludes that many of the claims made for the efficacy of...

STOCK MARKET COMMENTARY: TOKYO

27 April 1992

TOKYO: stocks were thinly traded last week, as foreign investors packed up for the Easter holiday, but the Nikkei Average...

STOCK MARKET COMMENTARY: NEW YORK

27 April 1992

NEW YORK: experienced a triple-witching hour ahead of the Easter weekend, which pushed the Dow Jones to a new high,...

Mexico Import Regulations

27 April 1992

The Mexican Ministry of Health has announced intensification of control measures to avoid the illegal entry of medi-cines from foreign...

JAPAN'S PROJECTED 1992 MEDICAL COSTS

27 April 1992

An increase of 6.9% to 23,170 billion yen ($172.62 billion) is expected in Japan's medical costs for the current year,...

Showing 94161-94170 of 95365 articles

Go to beginningPreviousNextGo to end